Product Name:3-(4-Methylphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one

IUPAC Name:3-(4-methylphenyl)-3H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one

CAS:17466-02-3
Molecular Formula:C11H9N5O
Purity:95%+
Catalog Number:CM577575
Molecular Weight:227.23

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:17466-02-3
Molecular Formula:C11H9N5O
Melting Point:-
Smiles Code:CC1=CC=C(C=C1)N1N=NC2=C1N=CNC2=O
Density:
Catalog Number:CM577575
Molecular Weight:227.23
Boiling Point:
MDL No:MFCD11588484
Storage:

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products



Product Other Information

Product Overview 3-(4-methylphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one is a chemical compound that has shown potential in various scientific research applications. It belongs to the class of triazolopyrimidine derivatives and has been synthesized using different methods.
Synthesis and Application The synthesis of 3-(4-methylphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one has been reported using different methods. One of the methods involves the reaction of 4-methylphenyl hydrazine with ethyl acetoacetate in the presence of acetic acid and sodium acetate. The resulting intermediate is then reacted with 2-chloro-4,6-dimethoxypyrimidine to yield the final product. Another method involves the reaction of 4-methylphenyl hydrazine with 2-chloro-4,6-dimethoxypyrimidine in the presence of sodium ethoxide and ethanol. 3-(4-methylphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one has shown potential in various scientific research applications. It has been reported to have anticancer, antifungal, antiviral, and anti-inflammatory activities. It has also shown potential as an anti-Alzheimer's agent and as a modulator of the immune system.
Future Directions There are several future directions for the research on 3-(4-methylphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one. One direction is to further investigate its mechanism of action and identify its molecular targets. Another direction is to conduct preclinical and clinical studies to evaluate its efficacy and safety in humans. Additionally, it may be useful to explore its potential in combination therapy with other drugs or as a drug delivery system. Finally, it may be worthwhile to investigate its potential as a diagnostic or imaging agent.